This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Harbour Biomed (Shanghai) Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Donghai Li
Introduction
Donghai Li is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work has led to advancements that could potentially impact cancer treatment.
Latest Patents
Donghai Li holds a patent for an "ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF." This innovative protein is designed to target and inhibit the PD-L1 pathway, which plays a crucial role in cancer cell evasion of the immune system. His patent portfolio includes 1 patent that showcases his expertise in this vital area of research.
Career Highlights
Currently, Donghai Li is employed at Harbour Biomed (Shanghai) Co., Ltd. His role at the company allows him to collaborate with other experts in the field, further enhancing his contributions to biotechnology. His work is characterized by a commitment to developing novel therapeutic solutions.
Collaborations
Donghai Li collaborates with Shuwen Ren, a fellow researcher, to advance their shared goals in the field of immunotherapy. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in medical science.
Conclusion
Donghai Li's contributions to biotechnology, particularly through his patent on anti-PD-L1 proteins, highlight his role as an influential inventor in the field. His work at Harbour Biomed continues to pave the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile